Aims: Mitochondrial stress and dysfunction within the intestinal epithelium are known to contribute to the pathogenesis of inflammatory bowel disease (IBD). However, the importance of mitophagy during intestinal inflammation remains poorly understood. The primary aim of this study was to investigate how the mitophagy protein BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L/NIX) mitigates mitochondrial damage during intestinal inflammation in the hopes that these data will allow us to target mitochondrial health in the intestinal epithelium as an adjunct to immune-based treatment strategies. Results: In the intestinal epithelium of patients with ulcerative colitis, we found that NIX was upregulated and targeted to the mitochondria. We obtained similar findings in wild-type mice undergoing experimental colitis. An increase in NIX expression was found to depend on stabilization of hypoxia-inducible factor-1 alpha (HIF1α), which binds to the Nix promoter region. Using the reactive oxygen species (ROS) scavenger MitoTEMPO, we were able to attenuate disease and inhibit both HIF1α stabilization and subsequent NIX expression, suggesting that mitochondrially derived ROS are crucial to initiating the mitophagic response during intestinal inflammation. We subjected a global Nix-/- mouse to dextran sodium sulfate colitis and found that these mice developed worse disease. In addition, Nix-/- mice were found to exhibit increased mitochondrial mass, likely due to the inability to clear damaged or dysfunctional mitochondria. Innovation: These results demonstrate the importance of mitophagy within the intestinal epithelium during IBD pathogenesis. Conclusion: NIX-mediated mitophagy is required to maintain intestinal homeostasis during inflammation, highlighting the impact of mitochondrial damage on IBD progression.
Aims: Mitochondrial stress and dysfunction within the intestinal epithelium are known to contribute to the pathogenesis of inflammatory bowel disease (IBD). However, the importance of mitophagy during intestinal inflammation remains poorly understood. The primary aim of this study was to investigate how the mitophagy protein BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (BNIP3L/NIX) mitigates mitochondrial damage during intestinal inflammation in the hopes that these data will allow us to target mitochondrial health in the intestinal epithelium as an adjunct to immune-based treatment strategies. Results: In the intestinal epithelium of patients with ulcerative colitis, we found that NIX was upregulated and targeted to the mitochondria. We obtained similar findings in wild-type mice undergoing experimental colitis. An increase in NIX expression was found to depend on stabilization of hypoxia-inducible factor-1 alpha (HIF1α), which binds to the Nix promoter region. Using the reactive oxygen species (ROS) scavenger MitoTEMPO, we were able to attenuate disease and inhibit both HIF1α stabilization and subsequent NIX expression, suggesting that mitochondrially derived ROS are crucial to initiating the mitophagic response during intestinal inflammation. We subjected a global Nix-/- mouse to dextran sodium sulfate colitis and found that these mice developed worse disease. In addition, Nix-/- mice were found to exhibit increased mitochondrial mass, likely due to the inability to clear damaged or dysfunctional mitochondria. Innovation: These results demonstrate the importance of mitophagy within the intestinal epithelium during IBD pathogenesis. Conclusion:NIX-mediated mitophagy is required to maintain intestinal homeostasis during inflammation, highlighting the impact of mitochondrial damage on IBD progression.
Entities:
Keywords:
HIF1α; hypoxia; inflammatory bowel disease; reactive oxygen species
Authors: Rachel L Schweers; Ji Zhang; Mindy S Randall; Melanie R Loyd; Weimin Li; Frank C Dorsey; Mondira Kundu; Joseph T Opferman; John L Cleveland; Jeffery L Miller; Paul A Ney Journal: Proc Natl Acad Sci U S A Date: 2007-11-29 Impact factor: 11.205
Authors: Ivana Novak; Vladimir Kirkin; David G McEwan; Ji Zhang; Philipp Wild; Alexis Rozenknop; Vladimir Rogov; Frank Löhr; Doris Popovic; Angelo Occhipinti; Andreas S Reichert; Janos Terzic; Volker Dötsch; Paul A Ney; Ivan Dikic Journal: EMBO Rep Date: 2009-12-11 Impact factor: 8.807
Authors: Anita S Gálvez; Eric W Brunskill; Yehia Marreez; Bonnie J Benner; Kelly M Regula; Lorrie A Kirschenbaum; Gerald W Dorn Journal: J Biol Chem Date: 2005-11-16 Impact factor: 5.157
Authors: Kellie E Cunningham; Garret Vincent; Chhinder P Sodhi; Elizabeth A Novak; Sarangarajan Ranganathan; Charlotte E Egan; Donna Beer Stolz; Matthew B Rogers; Brian Firek; Michael J Morowitz; George K Gittes; Brian S Zuckerbraun; David J Hackam; Kevin P Mollen Journal: J Biol Chem Date: 2016-03-11 Impact factor: 5.157
Authors: Murtaza M Tambuwala; Eoin P Cummins; Colin R Lenihan; Judit Kiss; Markus Stauch; Carsten C Scholz; Peter Fraisl; Felix Lasitschka; Martin Mollenhauer; Sean P Saunders; Patrick H Maxwell; Peter Carmeliet; Padraic G Fallon; Martin Schneider; Cormac T Taylor Journal: Gastroenterology Date: 2010-06-30 Impact factor: 22.682
Authors: Abhinav Diwan; Andrew G Koesters; Amy M Odley; Suvarnamala Pushkaran; Christopher P Baines; Benjamin T Spike; Diedre Daria; Anil G Jegga; Hartmut Geiger; Bruce J Aronow; Jeffery D Molkentin; Kay F Macleod; Theodosia A Kalfa; Gerald W Dorn Journal: Proc Natl Acad Sci U S A Date: 2007-04-09 Impact factor: 11.205
Authors: N S Chandel; E Maltepe; E Goldwasser; C E Mathieu; M C Simon; P T Schumacker Journal: Proc Natl Acad Sci U S A Date: 1998-09-29 Impact factor: 11.205
Authors: Lisa A Brennan; Rebecca McGreal-Estrada; Caitlin M Logan; Ales Cvekl; A Sue Menko; Marc Kantorow Journal: Exp Eye Res Date: 2018-06-04 Impact factor: 3.770
Authors: Jean-Philippe Leduc-Gaudet; Martin Picard; Félix St-Jean Pelletier; Nicolas Sgarioto; Marie-Joëlle Auger; Joanne Vallée; Richard Robitaille; David H St-Pierre; Gilles Gouspillou Journal: Oncotarget Date: 2015-07-20
Authors: Sidrah Khan; Heather L Mentrup; Elizabeth A Novak; Vei Shaun Siow; Qian Wang; Erin C Crawford; Corinne Schneider; Thomas E Comerford; Brian Firek; Matt B Rogers; Patricia Loughran; Michael J Morowitz; Kevin P Mollen Journal: FASEB J Date: 2022-05 Impact factor: 5.834